Anti-CD38 monoclonal antibody therapy
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Anti-CD38 monoclonal antibody therapy, covering 2025-08-07 to 2026-04-14. Get the full timeline:
Most recent: Clinical Trial Update: Fixed Duration vs Continuous Anti-CD38 Antibody Therapy Among Transplant Ineligible Older Adults With Newly-Diagnosed Multiple Myeloma [Phase 3]